Journal
COLLOIDS AND SURFACES B-BIOINTERFACES
Volume 122, Issue -, Pages 332-340Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.colsurfb.2014.07.018
Keywords
Cyclic RGD; Graphene oxide; pH-responsive; Controlled release; Hepatoma cells targeting
Funding
- Scientific Research Foundation of Fujian Provincial Department of Public Health [2012-2-110]
- Scientific Research Foundation of Xiamen Medical College [K2010-2]
Ask authors/readers for more resources
Polymers based on cyclic RGD-modified chitosan/graphene oxide are investigated in this paper as an innovative type of drug delivery system for hepatocellular carcinoma-targeted therapy and imaging. The system was prepared using a simple noncovalent method by coating drug-loaded graphene oxide (GO) with cyclic RGD-modified chitosan (RC). The results show that an efficient loading of doxorubicin (DOX) on GO (1.00 mg/mg) was obtained. The system exhibits a pH-responsive behavior because of the hydrogen bonding interaction between GO and RC, and may be very stable under physiological conditions but with release at a lower pH (tumor environment). In addition, cellular uptake and proliferation studies using hepatoma cells (Bel-7402, SMMC-7721, HepG2) indicated that the cRGD-modified chitosan/graphene oxide polymer could recognize hepatoma cells and promote drug uptake by the cells, especially for cells overexpressing integrins. Together, these results demonstrate that the RC/GO polymers provide a multifunctional drug delivery system with the ability to target hepatocarcinoma cells, and are pH-responsive and can be efficiently loaded with a number of therapeutic agents for biomedical applications. (C) 2014 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available